Experimental evidence on possibility to radiosensitize aggressive tumors by porphyrins.
Luksiene
Zivile
Z
Institute of Material Science and Applied Research, Vilnius University, Sauletekio 9, 10222 Vilnius, Lithuania. Zivile.Luksiene@mtmi.vu.lt
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy* / Q000532:radiotherapy*; D003037:Cobalt Radioisotopes / Q000627:therapeutic use; D003131:Combined Modality Therapy; D017323:Dihematoporphyrin Ether / Q000627:therapeutic use*; D005260:Female; D006415:Hematoporphyrins / Q000627:therapeutic use*; D008114:Liver Neoplasms, Experimental / Q000188:drug therapy* / Q000532:radiotherapy*; D051379:Mice; D008807:Mice, Inbred BALB C; D008811:Mice, Inbred DBA; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000627:therapeutic use*; D011166:Porphyrins; D011839:Radiation, Ionizing; D011838:Radiation-Sensitizing Agents; D011879:Radiotherapy Dosage
D000970:Antineoplastic Agents; D003037:Cobalt Radioisotopes; D006415:Hematoporphyrins; D017319:Photosensitizing Agents; D011166:Porphyrins; D011838:Radiation-Sensitizing Agents; D017323:Dihematoporphyrin Ether